FrancophonIA/ELRC3.0 huggingface dataset:
English: In the pivotal placebo-controlled study of Revatio in pulmonary arterial hypertension, a total of 207 patients were randomized to and treated with 20 mg, 40 mg or 80 mg TID doses of oral Revatio and 70 patients were randomized to placebo.
Maltese: Fl-istudju ewlieni ikkontrollat bi plaċebo ta' kif jaħdem Revatio fuq pressjoni għolja arterjali talpulmun, total ta' 207 pazjent ġew trattati b'mod każwali b'dożi ta' 20 mg, 40 mg, jew 80 mg TID ta' Revatio mill-ħalq u 70 pazjent li ngħataw il-plaċebo b'mod każwali.
English: This can happen if you are sick with a fever, vomiting, or diarrhoea - have a rare inherited eye disease (retinitis pigmentosa) - have an abnormality of red blood cells (sickle cell anaemia), (cancer of blood cells (leukaemia), cancer of bone marrow) (multiple myeloma), or any disease or deformity of the penis.
Maltese: Mhux magħruf tnaqqis fl-akutezza tal-vista, diplopja, sensazzjoni anormali fl-għajn Newropatija anterjuri iskimika, li mhix fl-arterja tal-għajn (NAION)*, sadd fis-sistema vaskulari ġewwa r-retina*, difett fil-kamp visiv*
English: • Alpha-blocker therapy (e.g. doxazosin) for the treatment of high blood pressure or prostate problems, as the combination of the two medicines may cause symptoms resulting in the lowering of your blood pressure (e.g. dizziness, light headedness).
Maltese: • Alpha-blockers (per eżempju doxazosin) għat-trattament ta' pressjoni għolja jew problemi filprostata, staqsi lit-tabib jew lill-ispiżjar tiegħek għal-parir qabel ma tieħu Revatio għaliex dawn iż-żewġ mediċini flimkien jistaw jirriżultaw f'sintomi ta' tnaqqis tal-pressjoni (e.ż. sturdament, tħossok li se jtik ħass hażin).
English: Intravenous administration
Maltese: Amministrazzjoni mill-vina
English: Pharmacotherapeutic group: Urologicals, Drugs used in erectile dysfunction, ATC code: G04BE03
Maltese: Meta jkun rikostitwit, it-trab iwassal għal suspensjoni orali bajda bit-togħma tal-għeneb.
English: Each film-coated tablet contains 20 mg of sildenafil (as citrate).
Maltese: Kull pillola miksija b'rita fiha 20 mg ta' sildenafil (bħala citrate).
English: Outcome of a referral procedure under Article 35 of Directive 2001/82/EC (EMEA/V/A/116)
Maltese: Riżultat ta' proċedura ta' referenza skont l-Artikolu 35 tadDirettiva 2001/82/KE (EMEA/V/A/116)
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom25 September 2017
Maltese: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom25 ta' Settembru 2017 EMA/707957/2017
English: What is moxidectin?
Maltese: X'inhu moxidectin?
English: The CVMP reviewed available data on PBT properties of moxidectin.
Maltese: Is-CVMP irreveda d-dejta disponibbli dwar karatteristiċi PBT ta' moxidectin.
English: These included data from companies and from the published literature.
Maltese: Din inkludiet dejta minn kumpaniji u mil-letteratura ppubblikata.
English: Why were veterinary medicines containing moxidectin reviewed?
Maltese: Għaliex ġew reveduti l-prodotti mediċinali veterinarji li fihom moxidectin?
English: Moxidectin is a broad-spectrum antiparasitic medicine widely used to treat and prevent parasitic infections (such as roundworms, fluke and lice) in both food-producing and companion animals.
Maltese: Moxidectin huwa mediċina antiparassitika ta' spettru wiesa' li tintuża ħafna biex tikkura u tipprevjeni infezzjonijiet parassitiċi (bħal ħniex, parassiti u qamel) f'kemm annimali li jipproduċu l-ikel kif ukoll f'annimali tal-kumpanija.
English: The CVMP recommended obtaining samples from relevant environmental compartments after use of the 5 mg/ml pour-on solution or 100 mg/ml injectable solution in beef cattle on pasture.
Maltese: Is-CVMP irrakkomanda l-ksib ta' kampjuni minn kompartimenti ambjentali relevanti wara l-użu ta' 5 mg/ml soluzzjoni li titferra' jew 100 mg/ml soluzzjoni injettabbli fi frat fuq il-mergħa.
English: On 11 May 2017, the European Medicines Agency completed a review of oral, topical and injectable moxidectin-containing veterinary medicines used in cattle, sheep and horses.
Maltese: Fil-11 ta' Mejju 2017, l-Aġenzija Ewropea għall-Mediċini temmet reviżjoni ta' mediċini veterinarji orali, topiċi u injettabbli li fihom moxidectin li jintużaw fil-frat, fin-nagħaġ u fiż-żwiemel.
English: On 22 October 2015, the German competent authority triggered a review of veterinary medicines containing moxidectin because of concerns that moxidectin may have PBT properties and could therefore pose a serious risk to the environment.
Maltese: Fit-22 ta' Ottubru 2015, l-awtorità kompetenti Ġermaniża tat bidu għal reviżjoni ta' mediċini veterinarji li fihom moxidectin minħabba tħassib li moxidectin jista' jkollu karatteristiċi PBT u għalhekk jista' joħloq riskju serju għall-ambjent.
English: The CVMP also noted that veterinary medicines containing moxidectin are an effective and important therapeutic option for treating internal and external parasites in cattle, sheep and horses.
Maltese: Is-CVMP innota wkoll li mediċini veterinarji li fihom moxidectin huma għażla terapewtika effettiva u importanti għall-kura ta' parassiti interni u esterni fil-frat, fin-nagħaġ u fiż-żwiemel.
English: In order to minimise the identified environmental risks, the CVMP recommended risk mitigation measures and warnings, to be included in the product information, including a precaution that treatment should only be given when necessary and should be based on faecal counts or an evaluation risk of infestation at the animal or herd level.
Maltese: Sabiex jiġu mminimizzati r-riskji ambjentali identifikati, is-CVMP irrakkomanda miżuri tal-mitigazzjoni tar-riskji u twissijiet, biex jiġu inklużi fl-informazzjoni dwar il-prodott, inkluż prekawzjoni li l-kura għandha tingħata biss meta tkun meħtieġa u għandha tiġi bbażata fuq l-għadd tal-ippurgar jew fuq evalwazzjoni ta' riskju ta' infestazzjoni fil-livell tal-annimal jew tal-merħla.
English: Which data has the CVMP reviewed?
Maltese: Liema dejta rreveda s-CVMP?
English: Consequently, the CVMP recommended measures to mitigate against the environmental risks, as well as warnings, to be included within the product information.
Maltese: Konsegwentement, is-CVMP irrakkomanda miżuri għall-mitigazzjoni kontra r-riskji ambjentali, kif ukoll twissijiet, biex jiġu inklużi fl-informazzjoni dwar il-prodott.
English: Based on the evaluation of the currently-available data from laboratory studies, the CVMP concluded that moxidectin fulfils the criteria to be considered a PBT substance, and that its use poses a risk to the environment.
Maltese: Abbażi tal-evalwazzjoni tad-dejta disponibbli bħalissa minn studji tal-laboratorju, is-CVMP ikkonkluda li moxidectin jissodisfa l-kriterji sabiex jiġi kkunsidrat sustanza PBT, u li l-użu tiegħu joħloq riskju għallambjent.
English: In addition, a condition was placed on the marketing authorisations with the purpose of obtaining field data to determine whether, under actual conditions of use and relevant environmental conditions, the hazards due to the PBT properties of these products can be prevented.
Maltese: Barra minn hekk, tpoġġiet kundizzjoni fuq l-awtorizzazzjonijiet għat-tqegħid fis-suq bl-iskop li tinkiseb dejta tal-post sabiex jiġi determinat jekk, taħt kundizzjonijiet tal-użu attwali u kundizzjonijiet ambjentali relevanti, ilperikli minħabba l-karatteristiċi PBT ta' dawn il-prodotti jistgħux jiġi evitati.
English: Common: Vertigo.
Maltese: Komuni: Vertigo.
English: There is a risk of severe strongyloidiasis.
Maltese: Hemm riskju ta' strongyloidiasis severa.
English: 17, Parc des Vautes 34980 Saint Gély du Fesc France
Maltese: 17, Parc des Vautes 34980 Saint Gély du Fesc Franza
English: 3 years.
Maltese: 3 sentejn.
English: Common: Cushing's syndrome;
Maltese: Komuni: Sindrome ta' Cushing;
English: Date of first authorisation: 16 March 2016
Maltese: Data tal-ewwel awtorizzazzjoni: 16 Marzu 2016
English: 92100 Boulogne-Billancourt France
Maltese: Boulogne-Billancourt Franza
English: Uncontrolled psychoses.
Maltese: Psikożi mhux ikkontrollata.
English: The volume of distribution is approximately 1 l/kg.
Maltese: Il-volum ta' distribuzzjoni huwa bejn wieħed u ieħor 1 l/kg.
English: − Frequent urination;
Maltese: − Urinazzjoni frekwenti;
English: neofordex UNIQUE IDENTIFIER - 2D BARCODE
Maltese: IDENTIFIKATUR UNIKU - BARCODE 2D
English: Pack size of 10 tablets.
Maltese: Daqs tal-pakkett ta' 10 pilloli.
English: Uncommon: Urticaria;
Maltese: Mhux komuni: Urtikarja;
English: Not known: Infection, sepsis.
Maltese: Infezzjoni, sepsis.
English: Multiple myeloma is a progressive rare haematologic disease.
Maltese: Il-majeloma multipla hija marda ematoloġika progressiva rari.
English: Tendonitis
Maltese: Tendonite
English: White, oblong (11 mm × 5.5 mm) tablet with a score-line on one face.
Maltese: Pillola bajda, oblunga (11 mm × 5.5 mm) b'linja ta' qsim fuq naħa waħda.
English: Elimination The plasma half-life of dexamethasone is approximately 250 minutes.
Maltese: Eliminazzjoni Il-half-life ta' dexamethasone fil-plażma hija madwar 250 minuta.
English: Neofordex may cause serious mental health problems.
Maltese: Neofordex jista' jikkawża problemi serji fis-saħħa mentali.
English: Not known: Mania, psychosis, behavioural disturbance.
Maltese: Mhux magħruf: Manija, psikosi, disturb tal-imġiba.
English: Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000 including isolated reports), not known (cannot be estimated from the available data).
Maltese: Ilfrekwenzi huma definiti bħala: komuni ħafna (≥ 1/10); komuni (≥ 1/100 sa < 1/10); mhux komuni (≥ 1/1,000 sa < 1/100); rari (≥ 1/10,000 sa < 1/1,000); rari ħafna (< 1/10,000 inklużi rapporti iżolati), mhux magħruf (ma tistax tittieħed stima mid-data disponibbli).
English: Adverse reactions to Neofordex correspond to the predictable safety profile of glucocorticoids.
Maltese: Ir-reazzjonijiet avversi għal Neofordex jaqblu mal-profil tas-sigurtà prevedibbli tal-glukokortikojdi.
English: Excipient with known effect: Each tablet contains 98.1 mg lactose (as monohydrate).
Maltese: Kull pillola fiha 98.1 mg lactose (bħala monohydrate).
English: Patients should be monitored clinically, including by endoscopy.
Maltese: Il-pazjenti għandhom jiġu mmonitorjati klinikament, inkluż permezz ta' endoskopija.
English: No interaction study has been performed with oral contraceptives.
Maltese: Ma sarux studji ta' interazzjoni ma' kontraċettivi orali.
English: Common: Atrial fibrillation, supraventricular extrasystoles, tachycardia, palpitations;
Maltese: Komuni: Fibrillazzjoni atrijali, extrasistoli sopraventrikolari, takikardija, palpitazzjonijiet;
English: - The other ingredients are lactose monohydrate, microcrystalline cellulose, magnesium stearate and colloidal anhydrous silica (see section 2).
Maltese: - Is-sustanzi l-oħra huma lattożju monohydrate, microcrystalline cellulose, magnesium stearate u colloidal anhydrous silica (ara sezzjoni 2).
English: Very common: Fatigue, asthenia, oedema (including peripheral and facial oedema);
Maltese: Komuni ħafna: Għeja, astenja, edima (inkluż edima periferali u filwiċċ);
English: Risk of infection
Maltese: Riskju ta' infezzjoni
English: Neofordex is indicated in adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products.
Maltese: Neofordex huwa indikat f'persuni adulti għall-kura ta' majeloma multipla sintomatika flimkien ma' prodotti mediċinali oħra.
English: − Cataract, blurred vision;
Maltese: − Katarretti, vista mċajpra;
English: Hepatic impairment or renal insufficiency
Maltese: Indeboliment epatiku jew insuffiċjenza renali
English: In Pom + LD-Dex treated patients neutropenia was infrequently serious (2.0% of patients), did not lead to treatment discontinuation, and was associated with treatment interruption in 21.0% of patients, and with dose reduction in 7.7% of patients.
Maltese: Fil-pazjenti kkurati b'Pom + LD-Dex, in-newtropenija rarament kienet serja (2.0% tal-pazjenti), ma waslitx għal waqfien tal-kura, u kienet assoċjata ma' interruzzjoni tal-kura f'21.0% tal-pazjenti, u ma' tnaqqis fid-doża f'7.7% tal-pazjenti.
English: Acute toxicity of dexamethasone is weak and toxic effects have rarely been observed after an acute overdose.
Maltese: It-tossiċità akuta ta' dexamethasone hija dgħajfa u rari kienu osservati effetti tossiċi wara doża eċċessiva akuta.
English: Neofordex 40 mg tablets
Maltese: Neofordex 40 mg pilloli
English: Neutropenia was Grade 3 or 4 in 41.7% of patients who received Pom + LD-Dex, compared with 14.8% who received HD-Dex.
Maltese: Newtropenija kienet ta' Grad 3 jew 4 f'41.7% tal-pazjenti li rċevew Pom + LD-Dex, meta mqabbla ma' 14.8% li rċevew HD-Dex.
English: Common: Liver function tests abnormal, alanine aminotransferase increased.
Maltese: Disturbi epatiċi u fil-marrara Komuni: Testijiet anormali tal-funzjoni tal-fwied, żieda fl-alanine aminotransferase.
English: Effects of other medicinal products on dexamethasone Dexamethasone is metabolized via cytochrome P450 3A4 (CYP3A4), and transported by the P-glycoprotein (P-gp, also known as MDR1).
Maltese: Dexamethasone jiġi metabolizzat permezz taċ-ċitokromu P450 3A4 (CYP3A4), u trasportat mill-glikoproteina-P (P-gp, magħrufa wkoll bħala MDR1).
English: − Failure of the thyroid gland to produce normal amounts of hormones (hypothyroidism);
Maltese: − Nuqqas taċ-ċellola tat-tirojde li tipproduċi ammonti normali ta' ormoni (ipotirojdiżmu);
English: • Erythromycin, due to increased metabolism of erythromycin in non-carriers of the CYP3A5*1 allele after dexamethasone treatment.
Maltese: • Erythromycin, minħabba ż-żieda fil-metaboliżmu ta' erythromycin f'nontrasportaturi tal-allele CYP3A5*1 wara kura b'dexamethasone.
English: Pharmacotherapeutic group: Corticosteroids for systemic use, glucocorticoids, ATC code: H02AB02
Maltese: Kortikosterojdi għall-użu sistemiku, glukokortikojdi, Kodiċi ATC:
English: It is characterized by excessive numbers of abnormal plasma cells in the bone marrow and overproduction of intact monoclonal immunoglobulin (IgG, IgA, IgD, or IgE) or Bence-Jones protein only (free immunoglobulin monoclonal κ and λ light chains).
Maltese: Hija kkaratterizzata minn ammonti eċċessivi ta' ċelloli anormali tal-plażma fil-mudullun u produzzjoni eċċessiva ta' immunoglobulina monoklonali intatta (IgG, IgA, IgD, jew IgE) jew proteina Bence-Jones biss (ktajjen ħfief liberi ta' κ u λ monoklonali talimmunoglubolina).
English: Dexamethasone has been shown to induce multiple myeloma cell death (apoptosis) via a down-regulation of Nuclear Factor-κB activity and an activation of caspase-9 through second mitochondria-derived activator of caspase (Smac; an apoptosis promoting factor) release.
Maltese: Dexamethasone ntwera li jikkawża mewt taċ-ċelloli tal-majeloma multipla (apoptosi) permezz ta' regolazzjoni 'l isfel tal-attività tal-Fattur-κB Nukleari u l-attivazzjoni ta' caspase-9 permezz ta' rilaxx tat-tieni attivatur ta' caspase derivat mill-mitokondrija (Smac; fattur li jippromwovi l-apoptosi).
English: • Anticonvulsants that are hepatic enzyme inducers: carbamazepine, fosphenytoin, phenobarbital, phenytoin, primidone, due to the reduction of dexamethasone plasma levels and hence its efficacy.
Maltese: • Antikonvulsanti li huma indutturi tal-enzimi epatiċi: carbamazepine, fosphenytoin, phenobarbital, phenytoin, primidone, minħabba t-tnaqqis tal-livelli ta' dexamethasone fil-plażma u għalhekk taleffikaċja tiegħu.
English: Dexamethasone has no clinically significant pharmacokinetic interaction with thalidomide, lenalidomide, pomalidomide, bortezomib, vincristine or doxorubicin.
Maltese: Dexamethasone ma għandu l-ebda interazzjoni farmakokinetika klinikament sinifikanti ma' thalidomide, lenalidomide, pomalidomide, bortezomib, vincristine jew doxorubicin.
English: • Clarithromycin, erythromycin, telithromycin, itraconazole, ketoconazole, posaconazole, voriconazole, nelfinavir, ritonavir: Increased dexamethasone plasma concentration due to reduction of its hepatic metabolism by these enzyme inhibitors.
Maltese: • Clarithromycin, erythromycin, telithromycin, itraconazole, ketoconazole, posaconazole, voriconazole, nelfinavir, ritonavir:
English: Dexamethasone is transported by the P-glycoprotein (also known as MDR1).
Maltese: Dexamethasone jiġi trasportat mill-glikoproteina-P (magħrufa wkoll bħala MDR1).
English: • With non-steroidal anti-inflammatory drugs (NSAIDs), due to an increased risk of gastrointestinal ulceration.
Maltese: • Ma' mediċini antiinfjammatorji mhux sterojdi (NSAIDs), minħabba ż-żieda fir-riskju ta' ulċerazzjoni gastro-intestinali.
English: It can also affect the nitro blue tetrazolium (NBT) test for bacterial infections and cause false-negative results.
Maltese: Jista' jaffettwa wkoll it-test ta' nitro blue tetrazolium (NBT) għal infezzjonijiet batteriċi u jikkawża riżultati negattivi foloz.
English: − Epileptic fits;
Maltese: − Attakki tal-epilessija;
English: Uncommon: Febrile neutropenia, pancytopenia, coagulopathy.
Maltese: Mhux komuni: Newtropenija bid-deni, panċitopenija, koagulopatija.
English: Dexamethasone apoptotic activity is enhanced by the combination with thalidomide or its analogues and with proteasome inhibitor (e.g. bortezomib).
Maltese: L-attività apoptotika ta' dexamethasone hija msaħħa bil-kombinazzjoni ma' thalidomide jew l-analogi tiegħu u bl-inibitur tal-proteasome (eż. bortezomib).
English: Dexamethasone is metabolized via cytochrome P450 3A4 (CYP3A4).
Maltese: Dexamethasone jiġi metabolizzat permezz taċ-ċitokromu P450 3A4 (CYP3A4).
English: Data on female fertility are contradictory.
Maltese: Id-dejta dwar il-fertilità tan-nisa hija kontradittorja.
English: (purpura);
Maltese: − Ħorriqija;
English: − Aggression, confusion, irritability, nervousness, restlessness, altered mood;
Maltese: − Aggressjoni, konfużjoni, irritabbiltà, nervożiżmu, irrekwitezza, tibdil fil-burdata;
English: Neofordex is a medicine that contains the active substance dexamethasone.
Maltese: Neofordex huwa mediċina li fiha s-sustanza attiva dexamethasone.
English: At high doses (e.g. 40 mg), it reduces the immune response.
Maltese: F'dożi għoljin (eż. 40 mg), huwa jnaqqas ir-rispons immunitarju.
English: Dexamethasone may cause confusional state, hallucinations, dizziness, somnolence, fatigue, syncope and blurred vision (see section 4.8).
Maltese: Dexamethasone jista' jikkawża stat konfużjonali, alluċinazzjonijiet, sturdament, ngħas, għeja, sinkope u vista mċajpra (ara sezzjoni 4.8).
English: Not known: Pancreatitis, gastrointestinal perforation, gastrointestinal haemorrhage, gastrointestinal ulcer.
Maltese: Mhux komuni: Pankreatite, perforazzjoni gastro-intestinali, emorraġija gastro-intestinali, ulċera gastro-intestinali.
English: Common: Peripheral neuropathy, dizziness, psychomotor hyperactivity, disturbance in attention, memory impairment, tremor, paraesthesia, headache, ageusia, dysgeusia, somnolence, lethargy, balance impaired, dysphonia;
Maltese: Newropatija periferali, sturdament, iperattività psikomotorja, disturb fl-attenzjoni, indeboliment tal-memorja, rogħda, parasteżija, uġigħ ta' ras, agewżja, disgewżja, ngħas, letarġija, indeboliment tal-bilanċ, disfonija;
English: Venous and arterial thromboembolic events
Maltese: Avvenimenti tromboemboliċi fil-vini u fl-arterji
English: High-dose (40 mg or 20 mg) oral dexamethasone has been studied in the therapy of multiple myeloma in combination with chemotherapy in the VAD regimen (vincristine, adriamycin/doxorubicin and dexamethasone) or in association with novel agents, including thalidomide and its analogues as well as proteasome inhibitors.
Maltese: Dexamethasone orali f'doża għolja (40 mg jew 20 mg) ġie studjat fit-terapija tal-majeloma multipla f'kombinazzjoni mal-kimoterapija firreġim VAD (vincristine, adriamycin/doxorubicin u dexamethasone) jew flimkien ma' sustanzi ġodda, inklużi thalidomide u l-analogi tiegħu kif ukoll l-inibituri tal-proteasome.
English: Vaccinations with inactivated vaccines are usually possible.
Maltese: Ġeneralment huwa possibbli tilqim b'vaċċini inattivati.
English: A haemoglobin concentration above 12 g/dl should lead to discontinuation of erythropoietic medicinal products.
Maltese: Konċentrazzjoni ta' emoglobina li tkun ogħla minn 12 g/dl għandha twassal għat-twaqqif tal-prodotti mediċinali eritropojetiċi.
English: If you are taking any of the following medicines, you should consult your doctor before taking Neofordex: - Anticoagulant medicines (which thin the blood) - Acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever, and other medicines to treat pain, inflammation and fever: ibuprofen, naproxen, diclofenac, meloxicam and others; - Medicines for treatment of hypertension or heart disease; - Medicines for treatment of diabetes; - Medicines for an upset stomach (for example antacids) and colestyramine (to lower cholesterol); - Medicines that reduce blood potassium levels: for example some diuretics or laxatives; - Cortisone or other corticosteroids, tetracosactide (used to test for adrenal function) or aminogluthetimide (used to treat Cushing's syndrome or breast cancer); - Antibiotics, with active substance names ending in -mycin and in -floxacin; antifungals (to treat fungal infections) with active substance names ending in -conazole or amphotericin B injection; and anti-HIV medicines with active substance names ending in -navir; - Rifampicin, rifabutin or isoniazid (used to treat tuberculosis); - Praziquantel or ivermectin (for certain worm infections); - Oestrogen hormones including the contraceptive pill and hormone replacement therapy (HRT); - Anticonvulsants (for the treatment of epilepsy) and midazolam (used as sleeping pill and for the treatment of epilepsy); - Aprepitant or fosaprepitant (for the treatment of nausea and vomiting after surgery or caused by chemotherapy [cancer treatment]); - Certain medicines to treat cancer: docetaxel, cyclophosphamide, lapatinib or methotrexate.
Maltese: Mediċini għal stonku mdejjaq (pereżempju l-antaċidi) u colestyramine (biex ibaxxi l-kolesterol); Mediċini li jnaqqsu l-livelli tal-potassju fid-demm: pereżempju xi dijuretiċi jew lassattivi; Cortisone jew kortikosterojdi oħra, tetracosactide(użat għall-ittestjar tal-funzjoni adrenali) jew aminogluthetimide (użat għall-kura tas-sindrome ta' Cushing jew il-kanċer tas-sider); Antibijotiċi, b'ismijiet ta' sustanzi attivi li jispiċċaw -mycin u -floxacin; antifungali (għall-kura ta' infezzjonijiet fungali) b'ismijiet ta' sustanzi attivi li jispiċċaw -conazole jew l-injezzjoni tal-amphotericin B; u mediċini kontra l-HIV b'ismijiet ta' sustanzi attivi li jispiċċaw -navir; Rifampicin, rifabutin jew isoniazid (użati għall-kura tat-tuberkulożi);
English: Not known: Purpura, bruising.
Maltese: Mhux komuni: Purpura, tbenġil.
English: Thrombocytopenia was Grade 3 or 4 in 20.7% of patients who received Pom + LD-Dex and in 24.2% who received HD-Dex.
Maltese: Tromboċitopenja kienet ta' Grad 3 jew 4 f'20.7% talpazjenti li rċevew Pom + LD-Dex u f'24.2 % li rċevew HD-Dex.
English: Dexamethasone also down-regulated anti apoptotic genes and increased IκB-α protein levels.
Maltese: Dexamethasone rregola 'l isfel ukoll il-ġeni apoptotiċi u żied il-liveli tal-proteina IκB-α.
English: • With erythropoietic medicinal products or other medicinal products that may increase the risk of thrombosis, such as hormone replacement therapy, in patients receiving thalidomide or its analogues with Neofordex (see sections 4.4 and 4.8).
Maltese: • Ma' prodotti mediċinali eritropojetiċi jew prodotti mediċinali oħra li jistgħu jżidu r-riskju ta' trombożi, bħat-terapija ta' sostituzzjoni tal-ormoni, f'pazjenti li jkunu qegħdin jirċievu thalidomide jew l-analogi tiegħu ma' Neofordex (ara sezzjonijiet 4.4 u 4.8).
English: Common: Neutropenia, anaemia, thrombocytopenia, lymphopenia, leukopenia, leukocytosis;
Maltese: Komuni: Newtropenija, anemija, tromboċitopenija, limfopenija, lewkopenija, lewkoċitosi;
English: • With methotrexate, due to an increased risk of haematological toxicity.
Maltese: • Ma' methotrexate, minħabba żieda fir-riskju ta' tossiċità ematoloġika.
English: Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.
Maltese: Tużax din il-mediċina wara d-data ta' skadenza li tidher fuq il-kartuna u l-folja wara EXP.